Author

@MartinShkreli

Shkreli is a former hedge-fund manager and biotech executive whose recent X feed includes stock-specific short theses such as QUBT, QBTS, and RGTI, and media have documented his po

trader score
+1.42
hit rate
65%
mean α
+3.41%
signals 14d
10

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 65% hit rate, +3.41% mean alpha, trader score +1.42. Their last-14d mentions, direction-adjusted, have moved -0.7% since posting (mean over 1 mentions with price data).

Recent signals10receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-24·@MartinShkreli·Reports a realized or portfolio performance gain of 3% since July 1 without identifying an asset.·
2026-08-21·@MartinShkreli·Reports a 5% gain since July 1 without identifying the asset.·
2026-08-19·@MartinShkreli·Reports a 5% gain since July 1 without identifying the asset.·
2026-08-18·@MartinShkreli·Argues the inflation-adjusted 1999–2002 market disaster will never be matched.·
2026-08-18·@MartinShkreli·Critiques low-affinity peptide probes as inferior to antibodies and unusable intracellularly.·
2026-08-17OABI@MartinShkreli+0.80Bullish OABI thesis cites a newly announced Lilly deal and a $15 author target.·
2026-08-17LLY@MartinShkreli+0.10Bullish OABI thesis cites a newly announced Lilly deal and a $15 author target.-0.7%
2026-08-17LGND@MartinShkreli+0.00Bullish OABI thesis cites a newly announced Lilly deal and a $15 author target.·
2026-08-17ARGX@MartinShkreli-0.10Questions whether ARGX is perversely rising on news; stance is mildly skeptical.·
2026-08-17·@MartinShkreli·Reports a 10% gain since July 1, but the referenced asset requires media context.·

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.